Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Efpeglenatide

AMPLITUDE-D

Sanofi · Phase 3 · Terminated · Enrollment 908

NCT03684642

EudraCT 2017-002956-10

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Efpeglenatide 4 mgn/rn/rn/rn/rn/r
Efpeglenatide 6 mgn/rn/rn/rn/rn/r
Dulaglutide 1.5 mgn/rn/rn/rn/rn/r

A count stays a count. This page does not turn a count into a percent.